Neuroone Medical Technologies annual gross profit
2010
2011
2012
2013
2021
2022
2023
2024
2025
Neuroone Medical Technologies Gross Profit Growth & History (NMTC)
Neuroone Medical Technologies's gross profit was $5.1M for fiscal 2025.
View full Neuroone Medical Technologies company overviewNeuroone Medical Technologies annual gross profit history
| Fiscal year | Period ended | Gross profit | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-09-30 | $5.1M | $4.1M | +376.20% |
| 2024 | 2024-09-30 | $1.1M | $623,150 | +136.50% |
| 2023 | 2023-09-30 | $456,517 | $527,311 | — |
| 2022 | 2022-09-30 | −$70,794 | $26,955 | — |
| 2021 | 2021-09-30 | −$97,749 | — | — |
| 2013 | 2013-12-31 | $1,249 | $328 | +35.61% |
| 2012 | 2012-12-31 | $921 | −$2,339 | −71.75% |
| 2011 | 2011-12-31 | $3,260 | $2,093 | +179.35% |
| 2010 | 2010-12-31 | $1,167 | — | — |
Neuroone Medical Technologies quarterly gross profit
Q1.11
Q2.11
Q3.11
Q4.11
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
Q2.13
Q3.13
Q4.13
Q1.14
Q2.14
Q3.14
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
Q3.26
| Fiscal quarter | Period ended | Gross profit | Change | YoY change |
|---|---|---|---|---|
| Q3 2026 | 2026-06-30 | $1.2M | $267,774 | +29.27% |
| Q2 2026 | 2026-03-31 | $990,264 | $219,203 | +28.43% |
| Q1 2026 | 2025-12-31 | $1.6M | −$359,061 | −18.63% |
| Q4 2025 | 2025-09-30 | $1.5M | $1.4M | +983.65% |
| Q3 2025 | 2025-06-30 | $914,835 | $632,963 | +224.56% |
| Q2 2025 | 2025-03-31 | $771,061 | $380,642 | +97.50% |
| Q1 2025 | 2024-12-31 | $1.9M | $1.7M | +623.54% |
| Q4 2024 | 2024-09-30 | $141,062 | −$52,593 | −27.16% |
| Q3 2024 | 2024-06-30 | $281,872 | $38,206 | +15.68% |
| Q2 2024 | 2024-03-31 | $390,419 | $358,916 | +1139.31% |
| Q1 2024 | 2023-12-31 | $266,314 | $278,621 | — |
| Q4 2023 | 2023-09-30 | $193,655 | $208,717 | — |
| Q3 2023 | 2023-06-30 | $243,666 | $250,079 | — |
| Q2 2023 | 2023-03-31 | $31,503 | $67,726 | — |
| Q1 2023 | 2022-12-31 | −$12,307 | $789 | — |
| Q4 2022 | 2022-09-30 | −$15,062 | $2,068 | — |
| Q3 2022 | 2022-06-30 | −$6,413 | $15,426 | — |
| Q2 2022 | 2022-03-31 | −$36,223 | −$15,100 | — |
| Q1 2022 | 2021-12-31 | −$13,096 | $24,561 | — |
| Q4 2021 | 2021-09-30 | −$17,130 | — | — |
| Q3 2021 | 2021-06-30 | −$21,839 | — | — |
| Q2 2021 | 2021-03-31 | −$21,123 | — | — |
| Q1 2021 | 2020-12-31 | −$37,657 | — | — |
| Q3 2014 | 2014-09-30 | $139 | −$113 | −44.84% |
| Q2 2014 | 2014-06-30 | $303 | −$148 | −32.82% |
| Q1 2014 | 2014-03-31 | $165 | −$241 | −59.36% |
| Q4 2013 | 2013-12-31 | $140 | −$220 | −61.11% |
| Q3 2013 | 2013-09-30 | $252 | $229 | +995.65% |
| Q2 2013 | 2013-06-30 | $451 | $60 | +15.35% |
| Q1 2013 | 2013-03-31 | $406 | $259 | +176.19% |
| Q4 2012 | 2012-12-31 | $360 | $2,201 | — |
| Q3 2012 | 2012-09-30 | $23 | −$789 | −97.17% |
| Q2 2012 | 2012-06-30 | $391 | −$827 | −67.90% |
| Q1 2012 | 2012-03-31 | $147 | −$2,924 | −95.21% |
| Q4 2011 | 2011-12-31 | −$1,841 | — | — |
| Q3 2011 | 2011-09-30 | $812 | — | — |
| Q2 2011 | 2011-06-30 | $1,218 | — | — |
| Q1 2011 | 2011-03-31 | $3,071 | — | — |
Neuroone Medical Technologies gross profit trends
Between the periods ended 2010-12-31 and 2025-09-30, Neuroone Medical Technologies's gross profit increased from $1,167 to $5.1M, a change of $5.1M. The latest reported quarter, Q3 2026, shows $1.2M.
About the metric
What gross profit means
Gross profit is the amount of revenue remaining after the direct costs of producing and delivering a company’s goods or services. It helps show the dollars available to cover operating expenses before operating income, interest, and taxes.
Calculation and source
SEC-reported and calculated gross profit
TickerStat uses gross profit reported in company SEC filings when available. Otherwise, it calculates gross profit as SEC-reported revenue minus aligned cost of revenue for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Neuroone Medical Technologies source filings ↗